We are live on ! Find out more
PVH

Psagot Value Holdings Portfolio holdings

AUM $11M
1-Year Est. Return 32.09%
This Fund
S&P 500
This Quarter Est. Return
+13.15%
1 Year Est. Return
+32.09%
3 Year Est. Return
+45.93%
5 Year Est. Return
+142.05%
10 Year Est. Return
+219.25%
AUM
$240M
AUM Growth
-$98.9M
Cap. Flow
-$121M
Cap. Flow %
-50.38%
Top 10 Hldgs %
35.9%
Holding
637
New
293
Increased
61
Reduced
110
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 29.63%
2 Communication Services 10.34%
3 Financials 10.2%
4 Healthcare 8.19%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQC
626
DELISTED
Equity Commonwealth
EQC
$0 ﹤0.01%
+21
New +$487
MRTX
627
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-500
Closed -$23K
FTCH
628
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
-101,140
Closed -$478K
ICPT
629
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-10,000
Closed -$124K
PDCE
630
DELISTED
PDC Energy, Inc.
PDCE
-3,000
Closed -$190K
SPPI
631
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-2,000
Closed -$1K
AYLA
632
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
-36,232
Closed -$14K
SIVB
633
DELISTED
SVB Financial Group
SIVB
-1,000
Closed -$230K
FM
634
DELISTED
iShares Frontier and Select EM ETF
FM
-707
Closed -$18K

Similar funds

Psagot Value Holdings's Q1 2023 Portfolio in Review

As of Q1 2023, Psagot Value Holdings held 637 positions worth $240M, down 29% from $339M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Psagot Value Holdings withdrew a net $121M in Q1 2023, closing 124 positions and reducing 110 holdings. Its most notable exit was ProShares UltraShort S&P500, an estimated $7.99M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 23% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Psagot Value Holdings opened a new position in Takeda Pharmaceutical worth $2.83M.

  • Psagot Value Holdings's largest Q1 2023 buy was Takeda Pharmaceutical: 174,300 shares worth $2.83M.
  • Psagot Value Holdings added most to Vanguard S&P 500 ETF in Q1 2023, an estimated $8.19M increase.
  • Psagot Value Holdings's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $8.5M.
  • Psagot Value Holdings fully exited ProShares UltraShort S&P500 in Q1 2023, selling an estimated $7.99M.
  • Psagot Value Holdings's ten largest holdings make up 36% of its $240M portfolio in Q1 2023.
  • Psagot Value Holdings opened 293 new positions and closed 124 in Q1 2023.
  • Psagot Value Holdings's portfolio value fell 29% quarter-over-quarter to $240M.

Based on Psagot Value Holdings's 13F filing for Q1 2023, filed 20 Jun 2023.